Roberto T Zori

Roberto T Zori, M.D.

Professor And Chief

Department: Pediatric Genetics and Metabolism
Business Phone: (352) 294-5050
Business Email: zorirt@peds.ufl.edu

About Roberto T Zori

Dr. Roberto Zori – Chief of Clinical Genetics and Metabolism/ Department of Pediatrics, Director of Cytogenetics; Interim Medical Director, Genetics/Molecular Pathology Laboratory Section; , Department of Pathology, Immunology and Laboratory, University of Forida;

Dr. Zori is a clinical geneticist and cytogeneticist. He is also a consultant to the craniofacial clinic for clinical genetics diagnostic and counseling issues

Clinical Profile

Specialties
  • Pediatric Genetics and Metabolism
  • Pediatrics
Subspecialties
  • Clinical Cytogenetics
Areas of Interest
  • Angelman syndrome
  • Cleft lip and palate
  • Genetics
  • Metabolism
  • Phenylketonuria

Publications

2019 Genetics in medicine : official journal of the American College of Medical Genetics
2015 The Journal of clinical endocrinology and metabolism
2015 Molecular Genetics and Metabolism
2015 Genetics in medicine : official journal of the American College of Medical Genetics
2012 Cytogenetic and genome research
2012 Genetics in medicine : official journal of the American College of Medical Genetics
2011 American journal of medical genetics. Part A
2008 American journal of human genetics
1995 Current problems in pediatrics
1995 American journal of medical genetics
1993 American journal of medical genetics
1992 Journal of child neurology
1991 American journal of medical genetics
1985 Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete

Grants

Jan 2018 ACTIVE
Training Program for Applied Research and Development in Genomic Medicine
NATL INST OF HLTH NHGRI ·
Jul 2016 ACTIVE
FLDOH CMS Long Term Genetics – COQXA
FL DEPT OF HLTH CHILDRENS MED SERVS · Principal Investigator
Jul 2016 ACTIVE
CMS Newborn Screening – COQWX
FL DEPT OF HLTH CHILDRENS MED SERVS ·
Apr 2015 – Apr 2018
An Open Label Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate (GPB; RAVICTI?) in Pediatric Subjects under Two Years of Age with Urea Cycle Disorders (UCDs)
HYPERION THERAPEUTICS INC · Principal Investigator
Jul 2014 – Jul 2022
Long-Term Registry of Patients With Urea Cycle Disorders (UCDs)
HYPERION THERAPEUTICS INC · Principal Investigator
Mar 2014 ACTIVE
ChORD (Children Overcoming Rare Disorders)
UF FOU · Principal Investigator
Jul 2013 – May 2021
A Three-Part, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Four-Arm, DiscontinuationStudy to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self Administered byAdults With Phenylketonuria (Prism Study 302)
BIOMARIN PHARMACEUTICAL · Principal Investigator
Apr 2013 – Apr 2019
BMN 165-301
BIOMARIN PHARMACEUTICAL · Principal Investigator
Dec 2011 – Dec 2022
Long-term Extension of a Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Efficacy, andTolerability of Multiple Subcutaneous Doses of rAvPALPEGin Subjects with PKU
BIOMARIN PHARMACEUTICAL · Principal Investigator
Jan 2011 – Jun 2016
Genetics/Newborn/Cystic Fibrosis Screening
FL DEPT OF HLTH · Principal Investigator
Dec 2010 – Dec 2016
PKU ASCEND (PKU-016)
BIOMARIN PHARMACEUTICAL · Principal Investigator
Dec 2009 – Dec 2018
PKUDOS – PKU Demographics, Outcomes, and Safety Registry
BIOMARIN PHARMACEUTICAL · Principal Investigator
Dec 2009 – Nov 2021
LSD Registry Program
GENZYME CORP · Principal Investigator
Sep 2002 ACTIVE
HAYWARD FOUNDATION GRANT
HAYWARD FOU, JOHN & WINIFRED · Project Manager

Education

Residency – Pediatrics
1990 · University of Florida
Residency – Pediatrics
1983 · Baystate Medical Center
Internship – Pediatrics
1981 · Baystate Medical Center
Medical Degree
1979 · Odense University, Denmark

Contact Details

Phones:
Business:
(352) 294-5050
Emails: